Roxatidine Acetate

Roxatidine Acetate

SCHEMBL1393

CC(=O)OCC(=O)NCCCOc1cccc(CN2CCCCC2)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HRH2 P25021 2/20 1.00
HRH3 Q9Y5N1 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Roxatidine Acetate SCHEMBL29965995 1.00 HRH2 (1.00) HRH2HRH3
SCHEMBL11399763 1.00 HRH2 (1.00) HRH2HRH3
Roxatidine Acetate SCHEMBL667643 0.99 HRH2 (0.98) HRH2HRH3
Roxatidine Acetate SCHEMBL29389759 0.99 HRH2 (0.98) HRH2HRH3
SCHEMBL11182082 0.99 HRH2 (0.98) HRH2HRH3
Roxatidine Acetate SCHEMBL9084471 0.98 HRH2 (0.96) HRH2HRH3
Roxatidine Acetate SCHEMBL1650455 0.98 HRH2 (0.96) HRH2HRH3
Roxatidine Acetate SCHEMBL482841 0.96 HRH2 (0.93) HRH2HRH3
Roxatidine Acetate SCHEMBL2322201 0.94 HRH2 (0.89) HRH2HRH3
SCHEMBL11179081 0.91 HRH2 (0.83) HRH2HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 6968 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026100654-A1 NUCLEIC ACID INTRODUCTION AID, NUCLEIC ACID INTRODUCTION AGENT, AND NUCLEIC ACID INTRODUCTION METHOD 株式会社インファーマシア 2026-05-15 WO claimed
WO-2026090593-A2 RNA BIOMARKERS FOR USE IN BARRETT'S ESOPHAGUS CITY OF HOPE (US) 2026-04-30 WO claimed
US-20260069593-A1 METHODS FOR TREATING CANCER AMGEN INC (US) 2026-03-12 US claimed
EP-4704971-A1 GAMMA STIMULATION AND NEUROMODULATOR COMBINATION THERAPY Cognito Therapeutics, Inc. (US) 2026-03-11 EP claimed
US-20250367126-A1 SOFTGEL CAPSULE COMPRISING A H2 RECEPTOR ANTAGONIST KENVUE BRANDS LLC (US) 2025-12-04 US claimed
EP-4630401-A2 CARBONIC ANHYDRASE ENZYME INHIBITORS AND METHODS OF USE THEREOF Rutgers, the State University of New Jersey (US) 2025-10-15 EP claimed
CN-115579052-B Proton pump inhibitors and H based on network toxicology analysis2Methods for receptor antagonist hepatotoxicity differentiation 重庆医科大学 2025-06-24 CN claimed
EP-4566590-A1 TASTE-MASKING MICROSPHERE, PREPARATION PROCESS THEREFOR, AND USE THEREOF Harbin Kanon Pharmaceutical Co., Ltd (CN) 2025-06-11 EP claimed
US-20250177398-A1 CARBONIC ANHYDRASE ENZYMES FOR REGULATING MAST CELL HEMATOPOIESIS AND TYPE 2 INFLAMMATION RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2025-06-05 US claimed
WO-2025111482-A1 COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS BEXSON BIOMEDICAL, INC. (US) 2025-05-30 WO claimed
WO-1993003711-A1 DOSAGE FORM FOR DELIVERING DRUG IN SHORT-TIME PERIOD ALZA CORPORATION (US) 1993-03-04 WO claimed
US-5178867-A Dosage form for delivering drug in short-time period ALZA CORPORATION (US) 1993-01-12 US claimed
EP-0275669-B1 USE OF HETEROCYCLIC DERIVATIVES FOR THE MANUFACTURE OF MEDICAMENTS GLAXO GROUP LIMITED (GB) 1992-09-30 EP claimed
EP-0454449-A1 Carboxylic acid derivatives GLAXO GROUP LIMITED (GB) 1991-10-30 EP claimed
EP-0367484-A1 Carboxylic acid derivates GLAXO GROUP LIMITED (GB) 1990-05-09 EP claimed
US-4915954-A Dosage form for delivering a drug at two different rates ALZA CORPORATION (US) 1990-04-10 US claimed
EP-0275669-A1 Use of heterocyclic derivatives for the manufacture of medicaments GLAXO GROUP LIMITED (GB) 1988-07-27 EP claimed
EP-0024510-B1 PHENOXYPROPYL AMINE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM TEIKOKU HORMONE MFG. CO., LTD. (JP) 1983-10-19 EP claimed
US-4293557-A AMIDES TEIKOKU HORMONE MFG. CO., LTD. (JP) 1981-10-06 US claimed
EP-0024510-A1 Phenoxypropyl amine derivatives, process for their preparation, and pharmaceutical compositions containing them TEIKOKU HORMONE MFG. CO., LTD. (JP) 1981-03-11 EP claimed